UNSPSC 51333503: Halopemide
Commodity
Code facts
- Part of
-
-
51000000
-
51330000
- 51333500
-
51330000
-
51000000
- NIGP codes
- 1
UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.
NIGP codes for 51333503
Definition
This classification denotes an antipsychotic agent with the molecular formula C21H22ClFN4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65Q28TV0ZY, chemically known as r 34,301 but generally known as halopemide, which bears US NIH Compound Identifier 65490. European Medicines Agency schedules Halopemide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08003MIG. The term HALOPEMIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18).
Read the full definition
HALOPEMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule halopemide under HS 29333999 and SITC 51574. As of Q4 2014, HALOPEMIDE remains the US FDA Preferred Term for this commodity. Halopemide bears US NLM identifiers UMLS ID C0062101 and NCI Concept Code C65840. SMILES: CLC1CC2[NH]C(=O)N(C3CCN(CC3)CCNC(=O)C3CCC(F)CC3)C2CC1.
About UNSPSC 51333503
UNSPSC 51333503 Halopemide is a Commodity code that in recent state and local procurement activity names pharmaceutical products and medical supply systems supporting community health and emergency response initiatives. The single recent opportunity in the dataset—Seminole County, Florida's IFB for naloxone and drug deactivation systems—suggests the code as currently tagged captures a narrow slice of pharmaceutical procurement rather than halopemide specifically. State and local issuing bodies using this code include county health departments and community health agencies pursuing competitive bidding for pharmaceutical inventory and related medical equipment. Vendors must meet standard compliance requirements including drug-free workplace certification, E-Verify confirmation, and proof of legal authorization to work in the United States, along with required insurance coverage (workers' compensation, commercial general liability, professional liability).
Seminole County, Florida represents the only recent activity tracked under this code. The county issued IFB 60459723LAS on June 30, 2026, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; bidders were required to include all shipping and delivery costs in their proposals, with responses due by July 26, 2023, at 2:00 pm. The contract structure includes an initial two-year term with a one-year renewal option and a three-month probationary period permitting termination with or without cause. The procurement notes potential FEMA funding, introducing federal compliance requirements under the Clean Air Act and Federal Water Pollution Control Act.
Quick answers
What is UNSPSC 51333503?
UNSPSC 51333503 is Halopemide, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.
Which NIGP codes match UNSPSC 51333503?
UNSPSC 51333503 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).
On GovTribe
See everything under UNSPSC 51333503
- State & local contract opportunities, awards and contract vehicles under this code
- Contacts who buy under this code
- Ask GovTribe AI about this code